FR14C0009I2 - Derives de la quinazoline, medicaments contenant ces composes, leur utilisation et leur procede de fabrication - Google Patents

Derives de la quinazoline, medicaments contenant ces composes, leur utilisation et leur procede de fabrication

Info

Publication number: FR14C0009I2
Authority: FR; France
Prior art keywords: compounds; manufacture; products containing; medicinal products; quinazoline derivatives
Prior art date: 2000-12-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR14C0009C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharma GmbH and Co KG

Original Assignee

Boehringer Ingelheim Pharma GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-20

Filing date

2014-01-30

Publication date

2014-11-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7667887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR14C0009(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-01-30 Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG

2014-03-07 Publication of FR14C0009I1 publication Critical patent/FR14C0009I1/fr

2014-11-14 Application granted granted Critical

2014-11-14 Publication of FR14C0009I2 publication Critical patent/FR14C0009I2/fr

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

FR14C0009C 2000-12-20 2014-01-30 Derives de la quinazoline, medicaments contenant ces composes, leur utilisation et leur procede de fabrication Active FR14C0009I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10063435A DE10063435A1 (de)	2000-12-20	2000-12-20	Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
PCT/EP2001/014569 WO2002050043A1 (fr)	2000-12-20	2001-12-12	Derives de la quinazoline, medicaments contenant ces composes, leur utilisation et leur procede de fabrication

Publications (2)

Publication Number	Publication Date
FR14C0009I1 FR14C0009I1 (fr)	2014-03-07
FR14C0009I2 true FR14C0009I2 (fr)	2014-11-14

Family

ID=7667887

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR14C0009C Active FR14C0009I2 (fr)	2000-12-20	2014-01-30	Derives de la quinazoline, medicaments contenant ces composes, leur utilisation et leur procede de fabrication

Country Status (40)

Country	Link
EP (2)	EP1345910B9 (fr)
JP (1)	JP3827641B2 (fr)
KR (1)	KR100852102B1 (fr)
CN (1)	CN1277822C (fr)
AR (1)	AR040524A1 (fr)
AT (1)	ATE430136T1 (fr)
AU (2)	AU1917402A (fr)
BE (1)	BE2014C009I2 (fr)
BG (1)	BG66139B1 (fr)
BR (1)	BRPI0116266B8 (fr)
CA (1)	CA2432428C (fr)
CY (2)	CY1109290T1 (fr)
CZ (1)	CZ302721B6 (fr)
DE (2)	DE10063435A1 (fr)
DK (1)	DK1345910T3 (fr)
EA (1)	EA006317B1 (fr)
EE (1)	EE05244B1 (fr)
ES (1)	ES2326617T3 (fr)
FR (1)	FR14C0009I2 (fr)
HK (1)	HK1060571A1 (fr)
HR (1)	HRP20030504B1 (fr)
HU (2)	HU228874B1 (fr)
IL (2)	IL156277A0 (fr)
LT (1)	LTC1345910I2 (fr)
LU (1)	LU92370I2 (fr)
ME (1)	ME02777B (fr)
MX (1)	MXPA03005559A (fr)
MY (1)	MY136086A (fr)
NO (3)	NO325672B1 (fr)
NZ (1)	NZ526918A (fr)
PL (1)	PL214798B1 (fr)
PT (1)	PT1345910E (fr)
RS (1)	RS50860B (fr)
SI (1)	SI1345910T1 (fr)
SK (1)	SK287573B6 (fr)
TW (1)	TWI295992B (fr)
UA (1)	UA74614C2 (fr)
UY (1)	UY27078A1 (fr)
WO (1)	WO2002050043A1 (fr)
ZA (1)	ZA200304141B (fr)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2375259C (fr)	1999-06-21	2009-04-28	Boehringer Ingelheim Pharma Kg	Heterocycles bicycliques, medicaments contenant lesdits composes, leur utilisation et procedes permettant de les preparer
US7019012B2 (en)	2000-12-20	2006-03-28	Boehringer Ingelheim International Pharma Gmbh & Co. Kg	Quinazoline derivatives and pharmaceutical compositions containing them
DE10204462A1 (de) *	2002-02-05	2003-08-07	Boehringer Ingelheim Pharma	Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
US20040044014A1 (en)	2002-04-19	2004-03-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
DE10221018A1 (de)	2002-05-11	2003-11-27	Boehringer Ingelheim Pharma	Verwendung von Hemmern der EGFR-vermittelten Signaltransduktion zur Behandlung von gutartiger Prostatahyperplasie (BPH)/Prostatahypertrophie
PE20040945A1 (es) *	2003-02-05	2004-12-14	Warner Lambert Co	Preparacion de quinazolinas substituidas
DE10307165A1 (de) *	2003-02-20	2004-09-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung
US7223749B2 (en)	2003-02-20	2007-05-29	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
US20050043233A1 (en)	2003-04-29	2005-02-24	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
DE10334226A1 (de) *	2003-07-28	2005-02-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
EP1667991B1 (fr)	2003-09-16	2008-05-14	Astrazeneca AB	Derives de quinazoline utilises comme inhibiteurs de la tyrosine kinase
US7456189B2 (en)	2003-09-30	2008-11-25	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
DE10349113A1 (de) *	2003-10-17	2005-05-12	Boehringer Ingelheim Pharma	Verfahren zur Herstellung von Aminocrotonylverbindungen
RS52119B (en) *	2004-05-06	2012-08-31	Warner-Lambert Company Llc	4-phenylamino-HINAZOLIN-6-IL-STARCHES
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
WO2006081741A1 (fr) *	2005-02-05	2006-08-10	Piaoyang Sun	Dérivés de quinazoline ou leurs sels de qualité pharmaceutique, synthèse et applications médicales desdites substances
KR100832594B1 (ko) *	2005-11-08	2008-05-27	한미약품 주식회사	다중저해제로서의 퀴나졸린 유도체 및 이의 제조방법
ES2412879T3 (es)	2005-11-11	2013-07-12	Boehringer Ingelheim International Gmbh	Tratamiento combinado del cáncer que comprende inhibidores de EGFR/HER2
WO2007054550A1 (fr) *	2005-11-11	2007-05-18	Boehringer Ingelheim International Gmbh	Derives de quinazoline pour le traitement des affections cancereuses
SI1981863T1 (sl) *	2006-01-26	2013-01-31	Boehringer Ingelheim International Gmbh	Postopek za pripravo aminokrotonilamino-substituiranih kinazolinskih derivatov
ATE552835T1 (de)	2006-09-18	2012-04-15	Boehringer Ingelheim Int	Verfahren zur behandlung von tumoren mit egfr- mutationen
EP1921070A1 (fr)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	heterocycles bicycliques, medicaments á base de ces composes, leur usage et procédé pour leur preparation
EP2118075A1 (fr)	2007-02-06	2009-11-18	Boehringer Ingelheim International GmbH	Hétérocycles bicycliques, agents pharmaceutiques contenant ces composés, leur utilisation et leur procédé de préparation
ME01461B (me)	2008-02-07	2014-04-20	Boehringer Ingelheim Int	Spirociklični heterocikli, ljekovi koji sadrže navedeno jedinjenje, njihova primjena i postupak za njihovu proizvodnju.
NZ589883A (en)	2008-05-13	2012-06-29	Astrazeneca Ab	Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy} quinazoline
PE20100252A1 (es)	2008-06-06	2010-04-12	Boehringer Ingelheim Int	Nuevas formulaciones farmaceuticas solidas que comprenden dimaleato de 4-[(3-cloro-4-fluorofenil) amino]-6-{[4-(n,n-dimetilamino)-1-oxo-2-buten-1-il] amino}-7-((s)-tetrahidrofuran-3-iloxi)-quinazolina
US8426430B2 (en)	2008-06-30	2013-04-23	Hutchison Medipharma Enterprises Limited	Quinazoline derivatives
CA2733153C (fr)	2008-08-08	2016-11-08	Boehringer Ingelheim International Gmbh	Heterocycles a substitution cyclohexyloxy, medicaments contenant ces composes, leur utilisation et procedes pour les preparer
WO2010054285A2 (fr)	2008-11-10	2010-05-14	National Health Research Institutes	Composés de pyrimidine bicycliques et tricycliques condensés à titre d'inhibiteurs de tyrosine kinase
WO2010081817A1 (fr)	2009-01-14	2010-07-22	Boehringer Ingelheim International Gmbh	Méthode de traitement d'un cancer colorectal
EP2429520A1 (fr)	2009-05-14	2012-03-21	Boehringer Ingelheim International GmbH	Nouvelle polytherapie destinee a traiter les maladies oncologiques et fibrotiques
US20120136004A1 (en) *	2009-05-14	2012-05-31	Boehringer Ingelheim International Gmbh	New combination therapy in treatment of cancer and fibrotic diseases
DK2451445T3 (da)	2009-07-06	2019-06-24	Boehringer Ingelheim Int	Fremgangsmåde til at tørre bibw2992, dets salte og faste farmaceutiske formuleringer omfattende denne aktive ingrediens
EP2509592A1 (fr)	2009-12-07	2012-10-17	Boehringer Ingelheim International GmbH	Bibw 2992 pour utilisation dans le traitement du cancer du sein triple négatif
CN105037333A (zh) *	2009-12-21	2015-11-11	张强	新的喹唑啉衍生物
US20120107304A1 (en)	2010-04-27	2012-05-03	Boehringer Ingelheim International Gmbh	Combination therapy in treatment of oncological and fibrotic diseases
SI2608792T1 (en)	2010-08-26	2018-02-28	Boehringer Ingelheim International Gmbh	Methods for the administration of an EGFR inhibitor
KR20130105675A (ko)	2010-11-25	2013-09-25	라티오팜 게엠베하	아파티닙의 신규 염 및 다형
SG10201601711SA (en)	2011-03-04	2016-04-28	Newgen Therapeutics Inc	Alkyne Substituted Quinazoline Compound And Methods Of Use
US8828391B2 (en)	2011-05-17	2014-09-09	Boehringer Ingelheim International Gmbh	Method for EGFR directed combination treatment of non-small cell lung cancer
CN102918029B (zh)	2011-05-17	2015-06-17	江苏康缘药业股份有限公司	4-苯胺-6-丁烯酰胺-7-烷醚喹唑啉衍生物及其制备方法和用途
CN102838590B (zh) *	2011-06-21	2014-07-09	苏州迈泰生物技术有限公司	氨基喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途
WO2013052157A1 (fr)	2011-10-06	2013-04-11	Ratiopharm Gmbh	Formes cristallines de di-maléate d'afatinib
CN103073539B (zh) *	2011-10-26	2016-05-11	齐鲁制药有限公司	4-(取代苯氨基)喹唑啉衍生物及其制备方法、药物组合物和用途
AU2013210438B2 (en)	2012-01-17	2016-11-10	Astellas Pharma Inc.	Pyrazine carboxamide compound
CN103772380A (zh) *	2012-10-23	2014-05-07	杨子娇	一类治疗房角狭窄的化合物及其用途
EP2951171A1 (fr)	2013-02-01	2015-12-09	Boehringer Ingelheim International GmbH	Dérivés de quinazoline radiomarqués
US20140303097A1 (en)	2013-04-05	2014-10-09	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en)	2013-04-05	2023-11-14	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
US20140303098A1 (en)	2013-04-05	2014-10-09	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
SI2986304T1 (sl)	2013-04-18	2022-04-29	Boehringer Ingelheim International Gmbh	Farmacevtski sestavek, postopki za zdravljenje in njegove uporabe
CN103254182A (zh) *	2013-05-10	2013-08-21	苏州明锐医药科技有限公司	一种阿法替尼的制备方法
WO2014180271A1 (fr) *	2013-05-10	2014-11-13	苏州明锐医药科技有限公司	Procédé de préparation de l'afatinib et intermédiaire associé
CN103254183B (zh) *	2013-05-10	2015-11-11	苏州明锐医药科技有限公司	阿法替尼的制备方法
WO2014183560A1 (fr) *	2013-05-16	2014-11-20	苏州明锐医药科技有限公司	Afatinib et procédé de préparation d'un intermédiaire de celui-ci
CN103242303B (zh) *	2013-05-16	2015-03-25	苏州明锐医药科技有限公司	阿法替尼的制备方法
CN104513229A (zh) *	2013-09-28	2015-04-15	正大天晴药业集团股份有限公司	喹唑啉衍生物及其制备方法
CN103755688B (zh) *	2013-12-24	2015-11-18	江苏奥赛康药业股份有限公司	一种阿法替尼化合物的制备方法
US9242965B2 (en) *	2013-12-31	2016-01-26	Boehringer Ingelheim International Gmbh	Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
EA031059B1 (ru)	2014-01-02	2018-11-30	Тева Фармасьютикалз Интернэшнл Гмбх	Кристаллическая форма альфа дималеата афатиниба
CN105315263B (zh) *	2014-07-30	2018-11-27	正大天晴药业集团股份有限公司	阿法替尼中间体的合成方法
EP3023421A1 (fr)	2014-11-21	2016-05-25	Sandoz Ag	Formes cristallines de dimaléate d'afatinib
CN105801568B (zh)	2015-01-15	2019-07-30	杭州普晒医药科技有限公司	阿法替尼一马来酸盐晶型及其制备方法和药物组合物
JP6704422B2 (ja)	2015-03-20	2020-06-03	チアタイティエンチンファーマシューティカルグループカンパニーリミテッドChia Tai Tianqing Pharmaceutical Group Co., Ltd.	キナゾリン誘導体の塩およびその製造方法
CN105175400B (zh) *	2015-09-29	2018-04-10	河北神威药业有限公司	一种阿法替尼中间体的制备方法
WO2017141271A1 (fr) *	2016-02-17	2017-08-24	Sun Pharmaceutical Industries Ltd.	Composition pharmaceutique stable d'afatinib
CN106442793B (zh) *	2016-10-21	2019-05-24	河北神威药业有限公司	一种制备阿法替尼的中间体及其对映异构体的检测方法
CA3039745A1 (fr)	2016-11-10	2018-05-17	Boehringer Ingelheim International Gmbh	Composition pharmaceutique, methodes de traitement et leurs utilisations
TWI808958B (zh)	2017-01-25	2023-07-21	美商特普醫葯公司	涉及二芳基巨環化合物之組合療法
WO2019126136A2 (fr)	2017-12-18	2019-06-27	Sterngreene, Inc.	Composés de pyrimidine utiles en tant qu'inhibiteurs de tyrosine kinase
CN110437163A (zh) *	2018-05-03	2019-11-12	斯特恩格林公司	作为酪氨酸激酶抑制剂的嘧啶类化合物
CN113382986A (zh)	2018-09-25	2021-09-10	黑钻治疗公司	酪氨酸激酶抑制剂组合物、其制备方法和使用方法
CN109265449B (zh) *	2018-11-07	2021-11-23	沈阳工业大学	Egfr和her2双靶点酪氨酸激酶抑制剂及制备方法和用途
CA3124330A1 (fr)	2018-12-21	2020-06-25	Daiichi Sankyo Company, Limited	Combinaison d'un conjugue anticorps-medicament et d'un inhibiteur de kinase
CN109824657A (zh) *	2019-03-26	2019-05-31	石药集团中奇制药技术（石家庄）有限公司	一种二马来酸阿法替尼新晶型及其制备方法和应用
CN110590682A (zh) *	2019-10-14	2019-12-20	重庆医科大学	一种制备阿法替尼杂质的方法以及制备的杂质
WO2021094379A1 (fr)	2019-11-12	2021-05-20	Astrazeneca Ab	Inhibiteurs de la fonction tyrosine kinase du récepteur de facteur de croissance épidermique pour le traitement du cancer
MX2022008874A (es)	2020-01-20	2022-08-11	Astrazeneca Ab	Inhibidores de la tirosina cinasa del receptor del factor de creciminto epidermico para el tratamiento del cancer.
US20210369709A1 (en)	2020-05-27	2021-12-02	Astrazeneca Ab	EGFR TKIs FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
TWI847289B (zh) *	2021-09-30	2024-07-01	大陸商北京賽特明強醫藥科技有限公司	喹唑啉類化合物、組合物及其應用
AU2023246862A1 (en)	2022-03-31	2024-10-31	Astrazeneca Ab	Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors in combination with an akt inhibitor for the treatment of cancer
WO2023209090A1 (fr)	2022-04-28	2023-11-02	Astrazeneca Ab	Composés hétéroaromatiques bicycliques et leur application dans le traitement du cancer
WO2023209088A1 (fr)	2022-04-28	2023-11-02	Astrazeneca Ab	Composés hétéroaromatiques bicycliques et leur utilisation dans le traitement du cancer
CN119156385A (zh)	2022-04-28	2024-12-17	阿斯利康(瑞典)有限公司	稠合双环杂芳族化合物及其在治疗癌症中的用途
WO2023209086A1 (fr)	2022-04-28	2023-11-02	Astrazeneca Ab	Composés hétéroaromatiques bicycliques pour le traitement du cancer
KR20250029133A (ko)	2022-06-27	2025-03-04	아스트라제네카 아베	암 치료를 위한 표피성장인자 수용체 티로신 키나제 억제제를 포함하는 조합물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100503580C (zh) *	1996-04-12	2009-06-24	沃尼尔·朗伯公司	酪氨酸激酶的不可逆抑制剂
ZA986732B (en) *	1997-07-29	1999-02-02	Warner Lambert Co	Irreversible inhibitiors of tyrosine kinases
ZA986729B (en) *	1997-07-29	1999-02-02	Warner Lambert Co	Irreversible inhibitors of tyrosine kinases
KR20020068261A (ko) *	1999-02-27	2002-08-27	베링거 잉겔하임 파르마 카게	티로신 키나제에 의해 매개되는 신호 변환에 대한 억제효과를 갖는 4-아미노-퀴나졸린 및 퀴놀린 유도체
DE19908567A1 (de) *	1999-02-27	2000-08-31	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE19911366A1 (de) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE19911509A1 (de) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
CA2375259C (fr) *	1999-06-21	2009-04-28	Boehringer Ingelheim Pharma Kg	Heterocycles bicycliques, medicaments contenant lesdits composes, leur utilisation et procedes permettant de les preparer
CA2403152C (fr) *	2000-04-08	2008-10-28	Boehringer Ingelheim Pharma Kg	Heterocycles bicycliques, compositions pharmaceutiques contenant ces composes, leur utilisation et leur procede de preparation

2000
- 2000-12-20 DE DE10063435A patent/DE10063435A1/de not_active Withdrawn
2001
- 2001-12-12 SI SI200130916T patent/SI1345910T1/sl unknown
- 2001-12-12 PT PT01271363T patent/PT1345910E/pt unknown
- 2001-12-12 CZ CZ20031930A patent/CZ302721B6/cs not_active IP Right Cessation
- 2001-12-12 IL IL15627701A patent/IL156277A0/xx unknown
- 2001-12-12 EE EEP200300300A patent/EE05244B1/xx active Protection Beyond IP Right Term
- 2001-12-12 EA EA200300671A patent/EA006317B1/ru not_active IP Right Cessation
- 2001-12-12 DE DE50114874T patent/DE50114874D1/de not_active Expired - Lifetime
- 2001-12-12 BR BRPI0116266A patent/BRPI0116266B8/pt not_active IP Right Cessation
- 2001-12-12 WO PCT/EP2001/014569 patent/WO2002050043A1/fr active Application Filing
- 2001-12-12 AT AT01271363T patent/ATE430136T1/de active
- 2001-12-12 EP EP01271363.2A patent/EP1345910B9/fr not_active Expired - Lifetime
- 2001-12-12 NZ NZ526918A patent/NZ526918A/en not_active IP Right Cessation
- 2001-12-12 ES ES01271363T patent/ES2326617T3/es not_active Expired - Lifetime
- 2001-12-12 HU HU0301852A patent/HU228874B1/hu active Protection Beyond IP Right Term
- 2001-12-12 DK DK01271363T patent/DK1345910T3/da active
- 2001-12-12 PL PL361798A patent/PL214798B1/pl unknown
- 2001-12-12 AU AU1917402A patent/AU1917402A/xx active Pending
- 2001-12-12 JP JP2002551540A patent/JP3827641B2/ja not_active Expired - Lifetime
- 2001-12-12 CN CNB018208665A patent/CN1277822C/zh not_active Expired - Lifetime
- 2001-12-12 AU AU2002219174A patent/AU2002219174B2/en active Active
- 2001-12-12 KR KR1020037008246A patent/KR100852102B1/ko not_active Expired - Lifetime
- 2001-12-12 ME MEP-2008-595A patent/ME02777B/fr unknown
- 2001-12-12 EP EP09158964A patent/EP2112140A1/fr not_active Withdrawn
- 2001-12-12 UA UA2003076821A patent/UA74614C2/uk unknown
- 2001-12-12 CA CA002432428A patent/CA2432428C/fr not_active Expired - Lifetime
- 2001-12-12 MX MXPA03005559A patent/MXPA03005559A/es active IP Right Grant
- 2001-12-12 SK SK771-2003A patent/SK287573B6/sk not_active IP Right Cessation
- 2001-12-12 RS YUP-496/03A patent/RS50860B/sr unknown
- 2001-12-17 UY UY27078A patent/UY27078A1/es not_active Application Discontinuation
- 2001-12-19 AR AR20010105883A patent/AR040524A1/es active Pending
- 2001-12-19 MY MYPI20015767A patent/MY136086A/en unknown
- 2001-12-19 TW TW090131520A patent/TWI295992B/zh active
2003
- 2003-05-28 ZA ZA200304141A patent/ZA200304141B/en unknown
- 2003-06-03 IL IL156277A patent/IL156277A/en active Protection Beyond IP Right Term
- 2003-06-16 NO NO20032726A patent/NO325672B1/no active Protection Beyond IP Right Term
- 2003-06-18 HR HR20030504A patent/HRP20030504B1/xx not_active IP Right Cessation
- 2003-06-19 BG BG107929A patent/BG66139B1/bg active Active
2004
- 2004-05-20 HK HK04103590A patent/HK1060571A1/xx not_active IP Right Cessation
2009
- 2009-07-23 CY CY20091100793T patent/CY1109290T1/el unknown
2014
- 2014-01-30 FR FR14C0009C patent/FR14C0009I2/fr active Active
- 2014-01-31 LU LU92370C patent/LU92370I2/fr unknown
- 2014-02-06 LT LTPA2014005C patent/LTC1345910I2/lt unknown
- 2014-02-11 NO NO2014003C patent/NO2014003I2/no not_active IP Right Cessation
- 2014-02-12 HU HUS1400005C patent/HUS1400005I1/hu unknown
- 2014-02-12 CY CY2014008C patent/CY2014008I2/el unknown
- 2014-02-18 BE BE2014C009C patent/BE2014C009I2/fr unknown
2022
- 2022-07-01 NO NO2022028C patent/NO2022028I1/no unknown

Also Published As

Publication number	Publication date
HUP0301852A2 (hu)	2003-09-29
RS50860B (sr)	2010-08-31
EA200300671A1 (ru)	2004-06-24
IL156277A0 (en)	2004-01-04
HK1060571A1 (en)	2004-08-13
NO20032726L (no)	2003-06-16
HUP0301852A3 (en)	2008-03-28
HUS1400005I1 (hu)	2017-08-28
CN1277822C (zh)	2006-10-04
BG66139B1 (bg)	2011-07-29
NO2022028I1 (no)	2022-07-01
PL214798B1 (pl)	2013-09-30
JP3827641B2 (ja)	2006-09-27
PL361798A1 (en)	2004-10-04
LTC1345910I2 (lt)	2022-06-10
AU1917402A (en)	2002-07-01
EE05244B1 (et)	2009-12-15
EP1345910B9 (fr)	2014-06-04
ES2326617T3 (es)	2009-10-16
DE50114874D1 (de)	2009-06-10
BE2014C009I2 (fr)	2021-02-04
CN1481370A (zh)	2004-03-10
UA74614C2 (en)	2006-01-16
NO2014003I1 (no)	2014-06-02
UY27078A1 (es)	2002-07-31
LU92370I2 (fr)	2014-03-31
ME02777B (fr)	2011-10-10
YU49603A (sh)	2006-05-25
EE200300300A (et)	2003-10-15
SK287573B6 (sk)	2011-03-04
NO325672B1 (no)	2008-07-07
EP1345910B1 (fr)	2009-04-29
BG107929A (bg)	2005-01-31
CA2432428A1 (fr)	2002-06-27
DK1345910T3 (da)	2009-07-20
MXPA03005559A (es)	2004-10-14
SI1345910T1 (sl)	2009-08-31
BRPI0116266B1 (pt)	2017-10-31
KR100852102B1 (ko)	2008-08-13
CZ20031930A3 (cs)	2003-10-15
BR0116266A (pt)	2004-02-17
IL156277A (en)	2009-12-24
CY2014008I1 (el)	2014-07-02
EP2112140A1 (fr)	2009-10-28
TWI295992B (en)	2008-04-21
EA006317B1 (ru)	2005-10-27
CZ302721B6 (cs)	2011-09-21
ATE430136T1 (de)	2009-05-15
SK7712003A3 (en)	2003-10-07
NO2014003I2 (no)	2015-10-19
MY136086A (en)	2008-08-29
CY2014008I2 (el)	2015-12-09
AR040524A1 (es)	2005-04-13
HRP20030504B1 (en)	2011-09-30
HRP20030504A2 (en)	2005-06-30
AU2002219174B2 (en)	2007-09-06
HU228874B1 (en)	2013-06-28
ZA200304141B (en)	2004-04-15
MEP59508A (en)	2011-05-10
WO2002050043A1 (fr)	2002-06-27
JP2004516283A (ja)	2004-06-03
NO20032726D0 (no)	2003-06-16
BRPI0116266B8 (pt)	2021-07-27
KR20030071787A (ko)	2003-09-06
CA2432428C (fr)	2009-09-01
PT1345910E (pt)	2009-07-14
DE10063435A1 (de)	2002-07-04
EP1345910A1 (fr)	2003-09-24
LU92370I9 (fr)	2019-01-17
ES2326617T9 (es)	2014-09-10
LTPA2014005I1 (lt)	2022-05-25
CY1109290T1 (el)	2014-07-02
FR14C0009I1 (fr)	2014-03-07
NZ526918A (en)	2006-11-30

Publication	Publication Date	Title
FR14C0009I2 (fr)	2014-11-14	Derives de la quinazoline, medicaments contenant ces composes, leur utilisation et leur procede de fabrication
FR16C0042I1 (fr)	2016-12-09	Derives de composes heterocycliques et medicaments
ATE396198T1 (de)	2008-06-15	17alpha-alkyl-17beta-oxy-estratriene und zwischenprodukte zu deren herstellung, verwendung der 17alpha-alkyl-17beta-oxy-estratriene zur herstellung von arzneimitteln sowie pharmazeutische präparate
MA27252A1 (fr)	2005-03-01	Diphenylazetidinones substituees, leur procede de preparation, medicaments contenant ces composes et leur utilisation
EE200100431A (et)	2002-12-16	16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
FR2816938B1 (fr)	2003-01-03	Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
MA27366A1 (fr)	2005-06-01	Nouveaux derives de thiophenylglycoside, methodes pour leur production, medicaments contenant lesdits composes et leur utilisation
NO20025592D0 (no)	2002-11-21	Kontinuerlig produksjon av farmasöytisk granulering
DE69907698D1 (de)	2003-06-12	Azetidinderivate, deren herstellung und sie enthaltende arzneimittel
IL149034A (en)	2009-09-01	Quinazoline derivatives, processes for their preparation, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for use in the production of an antiangiogenic and/or vascular permeabiltiy reducing effect
EE04354B1 (et)	2004-10-15	Indolüül-3-glüoksüülhappe derivaadid, nende kasutamine ravimite valmistamiseks ja neid sisaldavad kasvajavastase toimega ravimid
MA26599A1 (fr)	2004-12-20	Nouveaux derives de benzenesulfonyle, leur preparation et leur application en tant que medicament
EE200100037A (et)	2002-06-17	Bensotsüklohepteenid, nende valmistamise meetod, neid sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
NO20013560D0 (no)	2001-07-18	Polymorfer av telmisartan, fremgangsmåter for fremstilling derav og anvendelse derav for fremstilling av et medikament
FR2761066B1 (fr)	2000-11-24	Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
NO20013958L (no)	2001-10-15	Legemiddel for behandling av höyt blodtrykk
FR2776291B1 (fr)	2000-06-16	Nouveaux derives bis-benzamides, leur procede de fabrication, les compositions pharmaceutiques les contenant et leur utilisation comme medicament
EE200100422A (et)	2002-12-16	Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
FR2842525B1 (fr)	2005-05-13	Derives de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments et compositions pharmaceutiques les renfermant
FR2831537B1 (fr)	2008-02-29	Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation
NO975680L (no)	1998-02-05	Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform
FR2791980B1 (fr)	2001-07-06	Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
FR2805538B1 (fr)	2006-08-04	Nouveaux derives de flavones, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
EE200100544A (et)	2003-02-17	15-lülilised 8a- ja 9a-laktaamid, nende valmistamismeetod ja farmatseutiline kompositsioon
FR2803299B1 (fr)	2004-09-17	NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION